Lipoma of the uterus : Clinical and ethiopathological approach of 7 cases with immunohistochemical study of histogenesis

##plugins.themes.academic_pro.article.main##

Olfa El Amine El Hadj
Saadia Bouraoui
Carole Goutallier Ben Fadhel
Ahlem Lahmar
Sabeh Mzabi Regaya

Abstract

Background: Lipoleiomyoma of the uterus (LLU) is an extremely rare, benign, uterine tumour. This rare disease was unknown for a long time. Their histogenesis remains controversial.
Aim: To describe the clinical and pathological aspects of uterine lipoleiomyoma and to try to specify, by an immunohistochemical study, its degenerative or tumoral nature.
Methods: 7 cases of LLU were identified represented by 2 pure Lipoma and 5 Lipoleiomyoma. We performed an immunohistochemical study including anti-vimentin, anti-smooth muscle actin, anti PS-100, anti-desmin, anti-factor VIII and anti-HMB- 45. The results were correlated with the pathogenesis of this lesion.
Results: Immunohistochemical analysis showed an expression of PS 100 only in lipocytes whereas leiomyomatous cells express only smooth muscle actin.
Conclusion: Our study supports the benign tumoral nature of the fatty uterine lesions. Lipoleiomyomatous cells may originate from the transformation of a totipotent mesenchymal cell and not from a degenerative process.

Keywords:

Uterus, lipoma, leiomyoma, actin smooth muscle, VIII factor

##plugins.themes.academic_pro.article.details##

References

  1. Lin, KC, Sheu, BC, Huang SC. Lipoleiomyoma of the uterus. Int Gynoecol obstet 1999; 67: 47-9.
  2. Fujiwaki R, Ohnuma H, Miura H, Sawada K. Uterine lipoleiomyoma in an elderly patient: a case report. Arch Gynecol Obstet 2008; 277: 471-4.
  3. Resta L, Maiorano E, Piscitelli D, Botticella MA. Lipomatous tumors of the uterus. Clinico-pathological features of 10 cases with immunohistochemical study of histogenesis. Pathol Res Pract 1994; 190: 378-83.
  4. Fujimoto Y, Kasai K, Furuya M, et al. Pure uterine lipoma. J Obstet Gynecol Res 2006; 32: 520-3.
  5. Loffroy R, Nezzal N, Mejean N, Sagot P, Krausé D. Lipoleiomyoma of the uterus: imaging features. Gynecol Obstet Invest 2008; 66:73-5.
  6. Erdema G, Celikb O, Karakasa H et al. Pure uterine lipoma. Magnetic Resonance Imaging 2007; 25: 1232-1236.
  7. Balaton A, Vuong N, Chevillote R, Baviera E. Fibromyolipome du corps utérin: à propos d'une obsevation avec revue de la littérature médicale. J Gynecol Obstet Reprod 1985; 14: 473-476.
  8. Gentile R, Zarri M, De Lucchi F, Bellone F, Lapertosa G. Lipoleiomyoma of the uterus. Pathologica 1996; 88: 132-4.
  9. Sonobe H, Haayaashi K, Takahashi K. Lipoleiomyoma of the uterus: report of a case. Gan no Rinsho 1988; 34: 2019-22.
  10. Yamadori I, Koayaashi S, Ogino T, Ohmori M, Tanaka H, Jimbo T. Uterine leiomyoma with focus of fatty and cartilaginous differenciation. Acta obstet Gynecol Scand 1993; 72: 307-9.
  11. Pedeutour F, Quade BJ, Sornberger K et al. Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14. Gens Chromosomes Cancer 2000; 27: 209-15.